NSE: KRSNAA | BSE: 543328

Mid-range Performer

Download real time

790.20 -7.85 (-0.98%)

26.28% Gain from 52W Low

28,150 NSE+BSE Volume

NSE 14 Aug, 2025 3:31 PM (IST)

2,563.3

Market Cap

Below industry Median

1.3

Beta 1Year

Very High Volatility

Dividend

Krsnaa Diagnostics Ltd. has an upcoming dividend of ₹2.75 per share due on 12 Sep 2025 See details

Krsnaa Diagnostics Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for KRSNAA, BSE:543328 Krsnaa Diagnostics Ltd.

Search Inside the pdf :

Krsnaa Diagnostics Ltd.

19 Feb 2025

790.20

-0.98%

Maintaining a positive outlook whilst addressing short-term headwinds

Buy: Krsnaa Diagnostics Ltd.

Recommendation Target

Khambatta Securities

Krsnaa Diagnostics Limited’s (KDL’s) revenue decreased due to seasonal
factors and temporary operational issues. The Mumbai BMC project ended
earlier than expected, and the Maharashtra city and Madhya Pradesh MRI
installations experienced delays due to site handover issues which led to a
temporary dip in revenues.

Krsnaa Diagnostics Ltd. is trading above its 150 day SMA of 763.6

Krsnaa Diagnostics Ltd.

31 Oct 2024

790.20

-0.98%

KRSNAA DIAGNOSTICS LTD.

Buy: Krsnaa Diagnostics Ltd.

Ventura

Bridging the Gap: Quality Diagnostics at Fair Prices

Krsnaa Diagnostics Ltd. is trading below its 30 day SMA of 826.3

Krsnaa Diagnostics Ltd.

30 Oct 2024

790.20

-0.98%

Expanding footprint and leveraging AI

Hold: Krsnaa Diagnostics Ltd.

Target

Khambatta Securities

Krsnaa Diagnostics Limited (KDL) reported robust business growth in 2Q FY25. The company has its growth projection of 25% for the financial year.

Krsnaa Diagnostics Ltd. is trading below its 30 day SMA of 826.3

Krsnaa Diagnostics Ltd.

23 Aug 2024

790.20

-0.98%

Long-term potential is discounted into current valuations

Hold: Krsnaa Diagnostics Ltd.

Recommendation Target

Khambatta Securities

Krsnaa Diagnostics Limited’s (KDL’s) business growth remained healthy on a y-o-y basis. That said, the growth was lower than expectations.

Krsnaa Diagnostics L.. has an average target of 1368.00 from 2 brokers.

Krsnaa Diagnostics Ltd.

13 Feb 2022, 12:00AM

790.20

-0.98%

Krsnaa Diagnost

Buy: Krsnaa Diagnostics Ltd.

Target

Khambatta Securities

Krsnaa Diagnostics Ltd. is trading below its 30 day SMA of 826.3

Krsnaa Diagnostics Ltd.

03 Jan 2022

790.20

-0.98%

Krsnaa Diagnost

Buy: Krsnaa Diagnostics Ltd.

Khambatta Securities

Krsnaa Diagnostics L.. has an average target of 1368.00 from 2 brokers.

Krsnaa Diagnostics Ltd.

04 Aug 2021

790.20

-0.98%

Krsnaa Diagnostics Limited IPO Note

IPO Note: Krsnaa Diagnostics Ltd.

HDFC Securities

Krsnaa Diagnostics Limited IPO Note Issue Open: Aug 04 Aug 06 2021 Price Band: Rs. 933 954 (Discount of Rs 93 for the eligible employees) *Issue Size: 12,718,392 eq shares (Fresh Issue of 400 cr + Offer for sale of 8,525,520 eq sh) Issue Size: Rs.1186.6 1213.3 cr Reservation for: QIB atleast 75% eq sh Non Institutional atleast 15% eq sh Retail Upto 10% eq sh

Krsnaa Diagnostics Ltd. is trading above its 150 day SMA of 763.6

Krsnaa Diagnostics Ltd.

04 Aug 2021

790.20

-0.98%

Krsnaa Diagnostics Ltd. IPO Note

IPO Note: Krsnaa Diagnostics Ltd.

Ashika Research

15 Equity Shares and in multiples thereof. Public issue of 12,718,392 Equity shares of Face value Rs. 5 each, (Comprising of fresh issue of 4,192,872 Equity Shares* (Rs. 400 cr.) and Offer for Sale of...

Krsnaa Diagnostics L.. has an average target of 1368.00 from 2 brokers.

Krsnaa Diagnostics Ltd.

04 Aug 2021

790.20

-0.98%

KRSNAA DIAGNOSTICS LTD.

IPO Note: Krsnaa Diagnostics Ltd.

Ventura

IPO Note

Krsnaa Diagnostics L.. has an average target of 1368.00 from 2 brokers.

Krsnaa Diagnostics Ltd.

03 Aug 2021

790.20

-0.98%

Krsnaa Diagnostics Ltd : IPO

IPO Note: Krsnaa Diagnostics Ltd.

ICICI Securities Limited

The company believes it provides quality services at competitive rates while following accreditations and protocols in line with best industry practice. For example, the cost of radiology tests it provides is 45-60% lower than market rates while the cost of pathology tests are 40-60% lower than market rate. Long term contracts for better visibility The terms of contract with public health agencies ranges between two and 10 years and typically include a term extension clause based on performance and mutual agreement. Further, considering services at...

Krsnaa Diagnostics Ltd. is trading below its 30 day SMA of 826.3

VOTE: Is Krsnaa Diagnostics Ltd. worth buying?

65 Votes:

Buy 87.69%

Sell 4.62%

Hold 7.69%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf